Current advances in delivery of biotherapeutics across the blood-brain barrier.

@article{Rajadhyaksha2011CurrentAI,
  title={Current advances in delivery of biotherapeutics across the blood-brain barrier.},
  author={Manoj Rajadhyaksha and Tracey Boyden and Jennifer L. Liras and Ayman El-Kattan and Joanne Brodfuehrer},
  journal={Current drug discovery technologies},
  year={2011},
  volume={8 2},
  pages={
          87-101
        }
}
Significant efforts through genomic approaches have been dedicated toward the identification of novel protein-protein interactions as promising therapeutic targets for indications such as Alzheimer's disease, Parkinson's disease and neuropsychiatric disorders. Additionally, the number of biotherapeutic agents entering the Pharmaceutical sector continues to increase and according to EvaluatePharma's "World Preview 2014" report, "the compounded annual growth rate of biologics is expected to be 8… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Which drug or drug delivery system can change clinical practice for brain tumor therapy?

  • Neuro-oncology
  • 2013
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Nanotechnology for CNS delivery of bio-therapeutic agents

  • Drug Delivery and Translational Research
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND